Ra Capital Nexus Fund, L.P.
Director at Artiva Biotherapeutics, Inc. (ARTV); Director at Vor Biopharma Inc. (VOR)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+34.9%
vs. S&P 500+31.3%
Beat the market100%
Paper profit on buys−$531K
Total bought / sold$7.7M / $3.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 23SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 6,52216,817,543 held (+0%) | $8.94 | $58K | -22.4% |
| Jun 11SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 479,03915,683,034 held (+3%) | $6.91 | $3.3M | +0.4% |
| Jun 11SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 10315,683,137 held (+0%) | $7.00 | $721 | -0.9% |
| Jun 11SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 548,58016,231,717 held (+3%) | $7.91 | $4.3M | -12.3% |
| Oct 22SEC | VORVor Biopharma Inc. | Sell | 70,3661,432,806 held (−5%) | $29.63 | $2.1M | -32.8% |
| Oct 22SEC | VORVor Biopharma Inc. | Sell | 13,8171,287 held (−91%) | $29.63 | $409K | -32.8% |
| Oct 22SEC | VORVor Biopharma Inc. | Sell | 6,5531,426,253 held (−0%) | $30.12 | $197K | -33.9% |
| Oct 22SEC | VORVor Biopharma Inc. | Sell | 1,287 | $30.12 | $39K | -33.9% |
| Oct 22SEC | VORVor Biopharma Inc. | Sell | 25,0271,401,226 held (−2%) | $28.11 | $704K | -29.2% |
- Buy
Director Ra Capital Nexus Fund, L.P. bought $3.3M of ARTV at $6.91 — first open-market purchase in our records.
- Buy
Director Ra Capital Nexus Fund, L.P. bought $4.3M of ARTV at $7.91 — largest purchase by this insider in our records.
- Sell
Director Ra Capital Nexus Fund, L.P. sold $409K of VOR at $29.63 — cuts the stake by 91%.